Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Inflamm Bowel Dis. 2024 Jul 3;30(7):1189-1206. doi: 10.1093/ibd/izad319.
Monogenic causes of inflammatory bowel diseases (IBD) are increasingly being discovered. To date, much attention has been placed in those resulting from inborn errors of immunity. Therapeutic efforts have been largely focused on offering personalized immune modulation or curative bone marrow transplant for patients with IBD and underlying immune disorders. To date, less emphasis has been placed on monogenic causes of IBD that pertain to impairment of the intestinal epithelial barrier. Here, we provide a comprehensive review of monogenic causes of IBD that result in impaired intestinal epithelial barrier that are categorized into 6 important functions: (1) epithelial cell organization, (2) epithelial cell intrinsic functions, (3) epithelial cell apoptosis and necroptosis, (4) complement activation, (5) epithelial cell signaling, and (6) control of RNA degradation products. We illustrate how impairment of any of these categories can result in IBD. This work reviews the current understanding of the genes involved in maintaining the intestinal barrier, the inheritance patterns that result in dysfunction, features of IBD resulting from these disorders, and pertinent translational work in this field.
单基因病因导致的炎症性肠病(IBD)正逐渐被发现。迄今为止,人们对先天免疫缺陷引起的疾病给予了更多关注。治疗方法主要集中在为 IBD 患者和潜在免疫紊乱患者提供个性化免疫调节或根治性骨髓移植。到目前为止,人们对与肠道上皮屏障受损相关的 IBD 的单基因病因关注较少。在这里,我们全面综述了导致肠道上皮屏障受损的 IBD 的单基因病因,这些病因可分为 6 个重要功能:(1)上皮细胞组织;(2)上皮细胞内在功能;(3)上皮细胞凋亡和坏死;(4)补体激活;(5)上皮细胞信号转导;(6)RNA 降解产物的控制。我们说明了其中任何一类功能的障碍如何导致 IBD。本文综述了维持肠道屏障的相关基因、导致功能障碍的遗传模式、这些疾病导致的 IBD 特征,以及该领域的相关转化研究。